TLX News: Jubilant Radiopharma Joins Illuccix® Pharmacy Partner Network - 13th Jun 2022, 9:11pm

[annb0t]

MELBOURNE, Australia and INDIANAPOLIS, June 13, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce that its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga 68 gozetotide), is now available at selected pharmacies in the Jubilant Radiopharma network. Illuccix is now available to order from 139 pharmacy sites across the United States, ensuring scheduling flexibility and patient access to advanced prostate cancer...

>>> Read more: Jubilant Radiopharma Joins Illuccix® Pharmacy Partner Network